Print This Page
 

 

(Between 9am-6pm EST)

 

High-Impact Results

The MMRF Has a Singular Focus: Bringing More Effective Treatments to Patients - Faster


When the MMRF was founded in 1998, patients with multiple myeloma had little hope. There was very little research on the disease. The same drugs had been used for several decades, with no new innovations on the horizon. As a result, patients had a life expectancy of only 3 years. Since then, the MMRF’s urgent and revolutionary work with researchers, clinicians, and partners in the biotech and pharmaceutical industries has sparked new hope for patients and dramatically changed the treatment landscape. The results speak for themselves. Read more about the MMRF Pipeline.

Strength in Numbers—the MMRF Community

Click to see more information

Driving Breakthrough Treatments—Now

Click to see more information

Accelerating Timelines

Click to see more information

Uncovering New Insights Into the Disease

Click to see more information

A Groundbreaking First—Individualized Treatment

Click to see more information

Fiscal Responsibility

Click to see more information

 

See our accomplishments on this timeline